Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 29 04:00PM ET
3.84
Dollar change
-0.14
Percentage change
-3.52
%
IndexRUT P/E- EPS (ttm)-1.37 Insider Own13.18% Shs Outstand42.24M Perf Week-88.07%
Market Cap178.24M Forward P/E- EPS next Y-0.43 Insider Trans0.00% Shs Float41.77M Perf Month-85.23%
Income-17.66M PEG- EPS next Q-0.58 Inst Own29.65% Short Float43.29% Perf Quarter-86.62%
Sales0.00M P/S- EPS this Y62.79% Inst Trans5.82% Short Ratio4.24 Perf Half Y-82.57%
Book/sh3.47 P/B1.11 EPS next Y49.61% ROA-8.91% Short Interest18.08M Perf Year-81.30%
Cash/sh4.07 P/C0.94 EPS next 5Y- ROE-10.98% 52W Range3.65 - 42.20 Perf YTD-82.94%
Dividend Est.- P/FCF- EPS past 5Y-30.45% ROI-10.60% 52W High-90.90% Beta-0.82
Dividend TTM- Quick Ratio3.55 Sales past 5Y0.00% Gross Margin- 52W Low5.21% ATR (14)3.41
Dividend Ex-DateDec 13, 2012 Current Ratio3.55 EPS Y/Y TTM84.18% Oper. Margin0.00% RSI (14)23.52 Volatility18.43% 11.68%
Employees29 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom3.67 Target Price59.00
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q4.63% Payout- Rel Volume3.97 Prev Close3.98
Sales Surprise- EPS Surprise20.55% Sales Q/Q- EarningsNov 07 BMO Avg Volume4.26M Price3.84
SMA20-82.67% SMA50-84.92% SMA200-82.97% Trades Volume15,862,419 Change-3.52%
Date Action Analyst Rating Change Price Target Change
Nov-26-24Downgrade H.C. Wainwright Buy → Neutral
Oct-08-24Upgrade H.C. Wainwright Neutral → Buy $116
Jul-01-24Downgrade H.C. Wainwright Buy → Neutral
Nov-16-22Downgrade B. Riley Securities Buy → Neutral $44
Jul-15-21Downgrade Cantor Fitzgerald Overweight → Neutral $100
Jul-07-21Reiterated Maxim Group Buy $80 → $190
Apr-27-21Initiated B. Riley Securities Buy $78
Feb-16-21Reiterated H.C. Wainwright Buy $20 → $66
Oct-23-20Initiated Cantor Fitzgerald Overweight $24
Sep-23-20Upgrade H.C. Wainwright Neutral → Buy $20
Nov-25-24 04:15PM
03:57PM
09:19AM
07:30AM
Nov-24-24 08:01PM
08:30AM Loading…
Nov-18-24 08:30AM
Nov-07-24 07:55AM
Oct-31-24 08:30AM
Oct-17-24 09:19PM
Oct-09-24 08:29AM
Sep-27-24 03:36PM
10:10AM
Sep-26-24 06:15PM
Sep-24-24 08:30AM
Sep-09-24 08:30AM
08:31AM Loading…
Sep-03-24 08:31AM
Aug-17-24 10:44PM
08:22AM
Aug-08-24 08:00AM
Aug-06-24 10:00AM
Aug-05-24 09:01AM
Aug-01-24 08:30AM
Jul-30-24 08:15AM
Jul-17-24 12:26PM
08:00AM
Jul-08-24 04:45PM
Jul-05-24 07:30AM
Jul-04-24 07:47AM
Jul-01-24 03:54PM
01:30PM
11:20AM Loading…
11:20AM
10:40AM
Jun-28-24 06:14PM
03:58PM
Jun-27-24 03:38PM
May-23-24 09:55AM
May-10-24 08:53PM
04:02PM
May-08-24 11:00AM
May-01-24 09:10AM
Apr-30-24 01:16PM
Apr-15-24 09:20AM
Mar-25-24 09:13AM
Mar-13-24 10:45AM
Mar-04-24 09:15AM
Feb-28-24 09:14AM
Feb-23-24 11:30AM
Feb-08-24 10:39AM
Feb-07-24 09:08AM
Feb-05-24 02:35PM
Jan-05-24 11:46AM
09:12AM
Dec-26-23 05:06AM
Dec-15-23 06:06PM
Dec-13-23 11:10AM
Dec-12-23 02:02PM
09:13AM
Dec-08-23 07:31PM
Dec-07-23 04:01PM
Nov-14-23 09:53PM
Nov-07-23 09:39AM
09:01AM
Nov-06-23 09:15AM
Oct-31-23 08:15AM
Oct-25-23 09:15AM
Oct-19-23 09:59AM
Oct-16-23 07:01PM
05:26PM
Oct-13-23 03:29PM
03:29PM
12:45PM
11:21AM
Oct-12-23 11:43PM
Oct-06-23 03:13PM
Oct-05-23 09:15AM
Oct-02-23 09:00AM
Sep-18-23 09:15AM
Sep-14-23 06:30AM
Sep-13-23 05:20PM
Sep-11-23 09:10AM
Sep-06-23 09:15AM
Aug-29-23 07:30AM
Aug-03-23 09:07AM
Jul-29-23 11:30AM
Jul-13-23 07:31AM
Jul-05-23 11:44AM
09:15AM
Jun-27-23 09:15AM
Jun-12-23 10:19AM
09:15AM
Jun-01-23 09:15AM
May-30-23 12:06PM
May-23-23 09:50AM
May-12-23 04:39PM
May-11-23 02:40PM
09:15AM
May-08-23 09:15AM
May-01-23 09:00AM
Apr-26-23 09:12AM
Mar-09-23 09:45AM
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schoen EricOfficerNov 29 '24Proposed Sale3.8659,800230,966Nov 29 03:33 PM
ROBERTSON SANFORDDirectorApr 26 '24Option Exercise22.0069,0001,518,000955,851Apr 30 09:13 AM
Barry RichardDirectorApr 23 '24Option Exercise22.00176,0853,873,870469,562Apr 25 09:15 AM
Kupiec James WilliamChief Medical OfficerApr 18 '24Option Exercise22.001,50033,0004,000Apr 22 09:19 AM
Schoen EricChief Financial OfficerApr 17 '24Option Exercise22.001,50033,00021,300Apr 17 04:21 PM